investors
investors
NCT: Damien on 4 grams of NCT with over 99%...
🔬 Biomanufacturing breakthrough detailed: 4 grams of NCT produced at a 96% yield and with a...
investors
NCT: From concept to gram-scale quantity in...
🚀 Biomanufacturing breakthrough: Using our AI-powered, cell-free exozyme platform, we’ve gone...
investors
Slack Capital interview: Damien Perriman, CCO
Last week, Slack Capital - an Australian investment research publication - has released an...
investors
Slack Capital interview: Damien Perriman, CCO...
Last week, Slack Capital - an Australian investment research publication - has released an...
investors
Slack Capital interview: Tyler Korman, VP of...
This week, Slack Capital - an Australian investment research publication - has released an...
investors
eXoZymes launches subsidiary, NCTx, to unlock a...
At the yearly SynBioBeta conference, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of...
investors
AI transforming biotechnology: From form with...
Co-founder and VP of Development at eXoZymes, Dr. Paul Opgenorth, states: "The Large Language...
investors
Introducing our new CCO: Damien Perriman
Our new Chief Commercial Officer, Damien Perriman, brings more than two decades of experience in...
investors
CNBC closing bell footage from Feb 19, 2025
Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC. Credit: CNBC...
